Opportunities & Announcements

All NIAID-relevant grant funding opportunity announcements are listed here. Any amendments to an announcement will be listed in the funding opportunity announcement. For contracts, see NIAID Contract Solicitations. For other funding opportunity resources, see Find a Foundation or Other Funding Source.

Showing results filtered by:
Title Activity Code Posting Date Expiration Date
HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01 Clinical Trial Not Allowed)- RFA-AI-18-029 R01 July 24, 2018 December 6, 2018
HIV-1 Infection of the Central Nervous System (R01)- PA-17-100 R01 January 5, 2017 January 8, 2020
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)- PAR-18-319 P01 October 13, 2017 March 14, 2020
HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21)- PA-17-278 R21 May 12, 2017 May 8, 2020
HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R01)- PA-17-279 R01 May 12, 2017 May 8, 2020
Advancing HIV Therapeutic Vaccine Science (U01 Clinical Trial Required)- RFA-AI-18-015 U01 April 25, 2018 September 28, 2018
Sustained Release Innovation for HIV (SRI) (R61/R33 Clinical Trial Optional)- RFA-AI-18-006 R61/R33 June 11, 2018 December 1, 2018
Halting TB Transmission in HIV-Endemic and Other High-Transmission Settings (R01 Clinical Trial Not Allowed)- RFA-AI-18-037 R01 July 3, 2018 December 6, 2018
Modeling and Simulation to Optimize HIV Prevention Research (MS OPR) (R01 Clinical Trial not allowed)- RFA-AI-18-026 R01 June 19, 2018 December 14, 2018
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP)- PAR-16-262 R01 May 17, 2016 January 5, 2019
Optimization of Monoclonal Antibodies for Eliminating the HIV Reservoir- PAR-16-115 R01 February 25, 2016 January 10, 2019
Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design- PAR-16-254 R01 May 11, 2016 January 12, 2019
Phylodynamic Tracking of HIV Transmission (R01)- PAR-17-048 R01 November 4, 2016 March 16, 2019
Strategies for the Improvement of HIV Envelope Protein Expression and Yield (R41/R42)- PA-16-182 R41/R42 April 12, 2016 April 6, 2019
Strategies for the Improvement of HIV Envelope Protein Expression and Yield (R43/R44)- PA-16-184 R43/R44 April 12, 2016 April 6, 2019
The Use of mRNA for an HIV Envelope Vaccine (R43/R44)- PA-16-207 R43/R44 April 19, 2016 April 6, 2019
The Use of mRNA for an HIV Envelope Vaccine (R41/R42)- PA-16-208 R41/R42 April 19, 2016 April 6, 2019
Innovation for HIV Vaccine Discovery (R01)- PAR-17-263 R01 April 25, 2017 August 2, 2019
Advancing mAbs to Achieve a Drug-free Sustained HIV Virologic Remission (U01 Clinical Trial Required)- RFA-AI-18-022 U01 June 28, 2018 October 10, 2019
Detection of HIV for Self-Testing (R61/R33)- PAR-17-471 R61/R33 August 25, 2017 December 7, 2019
NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)- PA-17-114 R01 January 9, 2017 January 8, 2020
Eradication of HIV-1 From Central Nervous System Reservoirs (R01)- PA-17-084 R01 December 13, 2016 January 8, 2020
Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)- PA-17-113 R01 January 9, 2017 January 8, 2020
Getting to Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Not Allowed)- PAR-18-411 R01 November 16, 2017 March 14, 2020
Imaging the Persistent HIV Reservoir (R01)- PA-17-305 R01 June 6, 2017 May 8, 2020
Optimizing HIV Phylodynamics to Target and Interrogate Clusters (OPTICs) (R21)- PA-17-306 R21 June 7, 2017 May 8, 2020
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01)- PA-17-280 R01 May 12, 2017 May 8, 2020
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)- PA-17-281 R21 May 12, 2017 May 8, 2020
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)- PA-17-283 R01 May 12, 2017 September 8, 2020
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)- PA-17-282 R21 May 12, 2017 September 8, 2020
CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed) - PAR-18-895 R01 August 8, 2018 January 8, 2021
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R01 Clinical Trial Optional)- PA-18-651 R01 February 12, 2018 January 8, 2021
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R21 Clinical Trial Not Allowed)- PA-18-652 R21 February 12, 2018 January 8, 2021
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional)- PA-18-753 R01 April 11, 2018 May 8, 2021
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trial Not Allowed)- PA-18-754 R21 April 11, 2018 May 8, 2021
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)- PAR-18-764 R01 April 20, 2018 May 8, 2021